KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Non-Current Debt (2018 - 2024)

BioNTech SE's Non-Current Debt history spans 7 years, with the latest figure at $50.1 million for Q4 2024.

  • On a quarterly basis, Non-Current Debt rose 20.05% to $50.1 million in Q4 2024 year-over-year; TTM through Dec 2024 was $50.1 million, a 20.05% increase, with the full-year FY2024 number at $50.1 million, up 20.05% from a year prior.
  • Non-Current Debt hit $50.1 million in Q4 2024 for BioNTech SE, up from $41.7 million in the prior quarter.
  • Over the last five years, Non-Current Debt for BNTX hit a ceiling of $275.4 million in Q4 2020 and a floor of $6.2 million in Q4 2022.
  • Historically, Non-Current Debt has averaged $115.4 million across 5 years, with a median of $50.1 million in 2024.
  • Biggest five-year swings in Non-Current Debt: plummeted 96.94% in 2022 and later soared 570.79% in 2023.
  • Tracing BNTX's Non-Current Debt over 5 years: stood at $275.4 million in 2020, then dropped by 26.19% to $203.3 million in 2021, then plummeted by 96.94% to $6.2 million in 2022, then soared by 570.79% to $41.7 million in 2023, then rose by 20.05% to $50.1 million in 2024.
  • Business Quant data shows Non-Current Debt for BNTX at $50.1 million in Q4 2024, $41.7 million in Q4 2023, and $6.2 million in Q4 2022.